血管紧张素Ⅱ2型受体的发现发展与临床应用的研究进展  

Advances in discovery,development and clinical application of angiotensinⅡtype-2 receptor

作　　者：武梓萌 罗毅沣[1] 李倩(综述) 张剑锋(审校)[1] WU Zi-meng;LUO Yi-feng;LI Qian(Department of Emergency, the Second Affiliated Hospital of Guangxi Medical University, Nanning 530021, China)

机构地区：[1]广西医科大学第二附属医院急诊科,南宁530021

出　　处：《中国临床新医学》2021年第7期716-721,共6页CHINESE JOURNAL OF NEW CLINICAL MEDICINE

基　　金：国家自然科学基金项目(编号:81960343);广西科技计划项目(编号:AB17195002);广西自然科学基金项目(编号:2017GXNSFAA198249);贵港市科学研究与技术开发计划项目(编号:1903006)。

摘　　要：血管紧张素Ⅱ2型受体(AT2R)是一个尚未完全被揭示的肾素-血管紧张素系统(RAS)受体,近年来,学者们越来越重视该受体在临床的应用潜力。同时该受体也是新型冠状病毒肺炎(COVID-19)的关键损伤因素之一。该文就AT2R的发现、发展与临床应用进行综述,为临床适应证提供思路。AngiotensinⅡtype-2 receptor(AT2R)is a renin-angiotensin system(RAS)receptor that has not been fully revealed.In recent years,scholars have paid more and more attention to the potential of AT2R in clinical application.At the same time,AT2R is also one of the key damage factors of coronavirus disease 2019(COVID-19).In this paper,the advances in discovery,development and clinical application of AT2R are reviewed to provide ideas for clinical indications.

关 键 词：血管紧张素Ⅱ2型受体 新型冠状病毒肺炎 肾素-血管紧张素系统 血管紧张素Ⅱ1型受体 

分 类 号：R331[医药卫生—人体生理学]